Capabilities · Specialist manufacturing domains

Controlled-substance handling

A proposed service scope for regulated compound management, connecting secure storage, material accountability, process integration and applicable regulatory requirements.

PlannedCatalogue scope

Illustrative unbranded isolator glove-port ring detail.
Illustrative unbranded isolator glove-port ring detail. It does not depict Luang Pharma's project, products or installed equipment.

Service statusPlanned

Planned.

Technical boundaries and readiness need confirmation before an activity could be presented as available.

Basis · Catalogue scope

Status
PlannedNo available service asserted
Source-plan relationship
Catalogue scopeProposed catalogue expansion
Readiness
Not establishedProduct and process evidence needed
Facility roadmap
First commercial batch target Q1 2028 · indicativeNot a service date

01 · Proposed service scope

Start with the product and its container.

Controlled-substance handling is presented as a planned service domain. The exact product, material classification and technical route would define its scope and specific security requirements.

The initial Boten formulation-and-filling plan identifies five injectable presentation families. The proposed services catalogue adds controlled-substance capabilities, which lie outside the initial plan and would need scope confirmation.

Physical security infrastructure and strict material reconciliation are distinct technical and administrative subjects. Inclusion in a common catalogue does not establish that appropriate permissions are held.

Catalogue boundary

A planned catalogue for scoped evaluation. Inclusion does not establish installed, qualified, licensed or available capability.

02 · Presentation families

Match the route to the format.

Planned formats and their source relationship
FormatPlanning noteBasisStatus
Active pharmaceutical ingredientsSmall-molecule active ingredientsProposed management of regulated active materials; requires separate scope confirmation.Catalogue scopePlanned
Formulated drug productsTabletsProposed handling of finished regulated dosage forms; not established by the initial plan.Catalogue scopePlanned
Analytical reference standardsAnalytical method developmentProposed laboratory control of regulated reference materials for testing purposes.Catalogue scopePlanned

03 · Process scope for discussion

Make the sequence and its evidence visible.

01 · Process stage

Planned

Material classification assessment

Define the specific legal category and the corresponding handling constraints for the proposed material.

02 · Process stage

Planned

Security infrastructure review

Consider the required physical storage environment, access controls and continuous monitoring arrangements.

03 · Process stage

Planned

Receipt and verification protocols

Define procedures for secure material arrival, identity confirmation and the initial inventory entry.

04 · Process stage

Planned

Process integration and dispensing

Consider how regulated materials would be securely transferred and tracked during planned manufacturing operations.

05 · Process stage

Planned

Reconciliation and accountability

Define strict inventory accounting mechanisms, secure waste management pathways and required discrepancy investigation procedures.

06 · Process stage

Planned

Secure dispatch and handover

Connect approved product release with secure transport arrangements and documented custody transfer requirements.

Illustrative sequence

This is a technical discussion structure, not an operating procedure, approved process flow or representation of installed equipment.

04 · Supporting services

No service stands alone.

01PlannedCatalogue scope

Highly potent & cytotoxic products

Dedicated risk, containment and facility-segregation assessment.

Explore proposed scope

02PlannedCatalogue scope

Qualified storage & warehousing

Storage conditions, status segregation and supporting system evidence.

Explore proposed scope

03PlannedCatalogue scope

Manufacturing & quality documentation

Controlled technical records for the intended manufacturing scope.

Explore proposed scope

05 · Readiness questions

A service claim needs a defined evidence base.

Material classification
Exact chemical entity, designated legal category and intended processing application.
Facility and systems
Appropriate physical security infrastructure and validated electronic access controls.
Process evidence
Defined reconciliation parameters, secure transfer routes and strict material accountability procedures.
Quality responsibilities
Controlled oversight of receipt, dispensing, consumption and secure waste disposal.
Regulatory context
Applicable material handling permissions from the relevant national authority.
Technical agreement
Delegated responsibilities, reporting obligations and security boundaries for any engagement.

06 · Practical questions

Before a technical discussion.

Is this service currently available?

No. The service is Planned. This page is a scope proposal and does not establish an operating controlled-substance handling service.

Which product types are in scope?

No controlled-substance line is identified in the initial plan. Regulated compounds and their handling requirements in the wider catalogue would require separate scope confirmation.

What information helps define the question?

Identify the proposed material, exact legal classification, intended manufacturing stage, required inventory profiles and the technical question. Confidential data should only be shared through an agreed route.

Is there a service launch quarter?

No. No service-specific quarter is established. The project-wide indicative milestones do not commit any individual service to a start date.

Does a technical discussion establish supply?

No. Feasibility, scope, regulatory permissions, security evidence and any agreement would need to be established before a service or supply commitment.

Back to capabilities

Professional enquiries

Discuss a defined question.

Describe the presentation, development question and destination relevant to the proposed scope. Do not infer service availability from this planning page.

Contact Luang Pharma